2 September 2020
Evotec SE, a drug discovery and development solutions company, today announced a partnership agreement with the University of Oxford regarding access to biospecimens from the biobank Quality in Organ Donation (QUOD), an initiative of the Nuffield Department of Surgical Sciences (NDS) at the University of Oxford in close collaboration with the National Health Service Blood and Transplant (NHSBT) organisation in the UK.
Professor Fran Platt secures £1M funding over two years for vital Parkinson's Disease research, in collaboration with Pfizer
4 August 2020
There is an increasing body of genetic and biochemical evidence that points toward lysosomal dysfunction as a risk factor for developing age-related neurodegenerative disorders, including Parkinson’s disease (PD).
16 July 2020
Three companies at Oxford’s BioEscalator are developing new detection methods and have discovered potential therapeutics in the fight against COVID-19.
3 July 2020
UK Research and Innovation, Cancer Research UK and industry are investing more than £11 million in an Oxford-led artificial intelligence (AI) research programme to improve the diagnosis of lung cancer and other thoracic diseases.
2 July 2020
The European Commission has granted Marketing Authorisation to Janssen for a new Ebola vaccine, developed in partnership with the University of Oxford.
24 June 2020
Following a fantastic event, Theolytics was announced the winner of the BioEscalator’s inaugural Pitch Finale, which was kindly supported by Santander Universities UK.
16 June 2020
The Capture the Fracture Partnership aims to prevent 250 million fractures by 2025 and combat the global public health burden of osteoporosis.
8 June 2020
A team of radiologists and radiographers at Oxford University Hospitals and University of Oxford's Department of Oncology has secured a grant to customise a teaching platform to educate frontline NHS staff to diagnose COVID-19 using chest X-rays and CT scans.
12 May 2020
The BioEscalator’s inaugural Pitch Battle contest was held digitally at the pizza social on Friday 17 April. Eleven pitches in total were delivered by innovative companies in Oxford's medical research district, covering the broad range of drug discovery, drug development and diagnostics work being undertaken at the BioEscalator.
30 April 2020
The University of Oxford has today announced an agreement with the UK-based global biopharmaceutical company AstraZeneca for the further development, large-scale manufacture and potential distribution of the COVID-19 vaccine candidate currently being trialled by the University.
1 April 2020
System being used in John Warin isolation ward at Oxford's John Radcliffe Hospital
5 March 2020
Dr Nessa Carey will lead the strategic development and implementation of the Entrepreneur in Residence (EiR) programme in Medical Sciences, laying the foundation of a world-class innovation support ecosystem capable of accelerating the translation of world-leading research into innovative therapies, business and commercial products.
23 January 2020
Two University of Oxford alumni-led startups, iLoF and Pipra, secured funding in excess of €4M from the European Institute of Technology for Health (EIT Health).
14 January 2020
Up to 30,000 lives could be saved over the next decade thanks to a proposed pioneering government collaboration with pharmaceutical company Novartis to tackle heart disease – a leading cause of death in the UK.
Oxford partnership with the University of British Columbia promises to advance the field of Clinical Pharmacology and Therapeutics
6 December 2019
On 1 October 2019, the University of Oxford and the University of British Columbia (UBC) signed a Memorandum of Understanding, committing to work together to develop a new generation of clinical research leaders who will transform the translation of novel therapies from laboratory to clinic.
30 October 2019
The University of Oxford and its partner organisations have been awarded funding that will support the training of over 175 bioscience graduate students as part of £170 million investment in bioscience by the BBSRC (Biotechnology and Biosciences Research Council, part of UK Research and Innovation).
27 August 2019
Researchers at the University of Oxford have discovered that male fruit flies adjust their seminal fluid depending on the levels of competition from other males.
Oxford University, Sensyne Health, Evotec and OSI create new partnership called LAB10x to accelerate data-driven drug discovery powered by AI
12 August 2019
LAB10x aims to accelerate the commercialisation of the next generation of digital therapeutics and data-driven drug discovery from clinical artificial intelligence research and digital health innovations at Oxford University.
12 August 2019
Oxford Brain Diagnostics, a spinout from Oxford University, has been launched to deliver a new method for diagnosing Alzheimer’s Disease from MRI scans.
Clinical researchers at Oxford University announce new collaboration with Janssen to detect blood cancers sooner
12 August 2019
The new 7-year research collaboration with Janssen Research & Development, LLC (Janssen) will study patients at higher risk of developing certain types of blood cancers that arise from the immune system, such as chronic lymphocytic leukaemia and multiple myeloma, to identify markers that could be used to predict who will go on to develop symptomatic disease.